Cargando…
Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants
This Phase 1, randomized, double-blind, placebo-controlled study was conducted to evaluate the safety, tolerability and immunogenicity of different doses of ExPEC4V conjugate vaccine (4-16µg Polysaccharide [PS]/serotype) in healthy Japanese participants, stratified into younger (≥20 to <50 years)...
Autores principales: | Inoue, Megumi, Ogawa, Tetsuro, Tamura, Hiroshi, Hagiwara, Yosuke, Saito, Yuki, Abbanat, Darren, van den Dobbelsteen, Germie, Hermans, Peter, Thoelen, Stefan, Poolman, Jan, Ibarra de Palacios, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183137/ https://www.ncbi.nlm.nih.gov/pubmed/29771596 http://dx.doi.org/10.1080/21645515.2018.1474316 |
Ejemplares similares
-
2712. Safety and Immunogenicity of two Doses of ExPEC4V Vaccine Against Extraintestinal Pathogenic Escherichia coli Disease in Healthy Adult Participants
por: B Smith, William, et al.
Publicado: (2019) -
Identification of Risk Factors for Invasive Extraintestinal Pathogenic Escherichia coli (ExPEC) Disease
por: Clarke, Erik, et al.
Publicado: (2021) -
Genomic and Temporal Trends in Canine ExPEC Reflect Those of Human ExPEC
por: Elankumaran, Paarthiphan, et al.
Publicado: (2022) -
Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic E. coli (ExPEC)
por: Lu, Hao, et al.
Publicado: (2020) -
Antibiotic Resistance and Virulence of Extraintestinal Pathogenic Escherichia coli (ExPEC) Vary According to Molecular Types
por: Duan, Yitao, et al.
Publicado: (2020)